Close Menu

NCT

A partnership involving Heidelberg University Hospital, the National Center for Tumor Diseases, and the German Cancer Research Institute is serving patients across Germany.

The tumor cell genome of 250 prostate cancer patients ages 50 and younger will be compared with gene sequences from healthy cells to uncover gene mutations that can cause and promote prostate cancer, and ultimately to create a map of all genetic modifications involving prostate cancer.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.